Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. - Freedman ND; Curto TM; Morishima C; Seeff LB; Goodman ZD; Wright EC; Sinha R; Everhart JE (Alimentary pharmacology & therapeutics, 2011)